Osmetech is betting the five-year deal will expand its sales and marketing efforts in the US and allow it to allocate more resources towards bringing its pipeline of tests to market.
Life Technologies announced today that it has been named to the FTSE4 Good Index Series, which includes companies that reach rigorous social, ethical, and environmental criteria.
Bruker, NextGen, Sigma-Aldrich, Bio-Rad, Waters, Pressure BioSciences, PSI, Xencor, Pfizer
The $3 million Stem Cell Commercialization Facility will open in June within 2,508 square feet of TechOne, the 100,000-square-foot first building of up to three that are planned to comprise the tech park, called TechTown.
Tepnel's shareholders will vote on the deal next month, with the $132.1 million offer expected to take effect in April.
Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.
The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.
ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.
In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.